Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950123-98-010826
Filing Date
1998-12-23
Accepted
1998-12-23 00:00:00
Documents
4
Period of Report
1998-09-30

Document Format Files

Seq Description Document Type Size
1 OSI PHARMACEUTICALS, INC. 10-K 265031
2 SUBSIDIARIES OF THE COMPANY EX-21 469
3 CONSENT OF KPMG PEAT MARWICK, LLP EX-23 998
4 FINANCIAL DATA SCHEDULE EX-27 2057
  Complete submission text file 0000950123-98-010826.txt   270406
Mailing Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553-3649
Business Address 106 CHARLES LINDBERGH BLVD UNIONDALE NY 11553 5162220023
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-15190 | Film No.: 98774136
SIC: 2835 In Vitro & In Vivo Diagnostic Substances